Pulse Biosciences Showcases Groundbreaking nsPFA Technology
Pulse Biosciences, Inc. (Nasdaq: PLSE), a leader in the field of bioelectric medicine, has recently announced that its cutting-edge nanosecond Pulsed Field Ablation™ (nsPFA) technology will be on display at an eminent annual meeting of the North American Society for Interventional Thyroidology. This event promises to be a significant opportunity for the company to share insights and advancements in their technology.
Innovative Applications of Nanosecond PFA Technology
The nsPFA technology employs a unique approach to soft tissue ablation that not only minimizes damage to surrounding tissues but also aims to improve treatment outcomes for patients. Paul LaViolette, Co-Chairman and CEO of Pulse Biosciences, stated that their nanosecond percutaneous electrode system is poised to provide effective treatment for symptomatic benign thyroid nodules. The underlying principle of nsPFA technology is its nonthermal mechanism, which effectively reduces scarring and preserves vital anatomical structures such as nerves and blood vessels.
Key Presentations at the Annual Meeting
The annual meeting will feature a series of critical presentations that highlight the experience and effectiveness of the nsPFA technology:
Friday, January 31
- 4:40 PM - Early Clinical Experience with Nanosecond Pulsed Field Ablation in a Series of Patients with Benign Thyroid Nodules by Dr. Camila Mancera.
Saturday, February 1
- 3:15 PM - Video Sessions: Key Techniques - Nanopulse presented by Dr. Stefano Spiezia.
Pulse Biosciences will also host an exhibit booth, providing an interactive platform for attendees to learn more about their innovations and technologies in the healthcare sector.
About Pulse Biosciences
Pulse Biosciences is dedicated to advancing healthcare through innovative technology. Their flagship CellFX® nsPFA™ technology utilizes nanosecond pulses of electrical energy, ensuring that cells can be cleared effectively without harming adjacent tissue. The company is focused on developing this technology for various applications, most notably in atrial fibrillation treatment, with the intention to improve healthcare outcomes.
With headquarters in Miami, Florida, and an office in Hayward, California, Pulse Biosciences continues to expand its reach and innovate, ensuring that their technologies address critical healthcare challenges.
Frequently Asked Questions
What is Pulse Biosciences known for?
Pulse Biosciences is known for its innovative nanosecond Pulsed Field Ablation technology, which is utilized in soft tissue ablation procedures.
What will be presented at the North American Society for Interventional Thyroidology Meeting?
The meeting will feature presentations on early clinical experiences with nsPFA technology and specifically its application for benign thyroid nodules.
What are the benefits of nsPFA technology?
NsPFA technology provides effective tissue ablation while minimizing scarring and preserving surrounding critical structures like nerves and vessels.
Who are the key figures at Pulse Biosciences?
Paul LaViolette serves as the Co-Chairman and CEO, leading the company's efforts in innovation and technology development.
Where is Pulse Biosciences based?
The company is headquartered in Miami, Florida, with a significant office in Hayward, California.
